Lowly Expressed Ribosomal Protein S19 in the Feces of Patients with Colorectal Cancer
The Kaplan-Meier overall survival curves in patients with colorectal cancer according to fecal RPS19. The relative mRNA levels of RPS19 in the feces are stratified into two groups: RPS19− (<2.7610−5) and RPS19+ (≥2.7610−5). The six-year overall survival rate of the RPS19+ group () is better than that of the RPS19− group (, log-rank test).
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.